UAE Cytomegalovirus Therapeutics Market Analysis

UAE Cytomegalovirus Therapeutics Market Analysis


$ 3999

UAE Cytomegalovirus Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. A member of the Herpesviridae family with an envelope, the human herpesvirus 5 (HHV-5) is also referred to as cytomegalovirus. Around 40% to 100% of adults worldwide have experienced HHV-5 exposure at some point in their lifetime, making it a very common virus. A rise in the frequency of cytomegalovirus infection, investments in research & development, and the introduction of novel medicines are some of the reasons driving the growth of the market for cytomegalovirus therapeutics. Several Global pharmaceutical firms, including Moderna, China Immunotech, Nobelpharma, Hookipa Biotech GmbH, Biotest, AlloVir, Merck Sharp & Dohme LLC, Chimerix, VBI Vaccines, Atara Biotherapeutics, SpyBiotech, MEMO Therapeutics, Lion TCR, and others are active in this Cytomegalovirus Therapeutics market.

ID: IN10AERD019 CATEGORY: Rare Diseases GEOGRAPHY: UAE AUTHOR: Sakshi Mantri

Buy Now

UAE Cytomegalovirus Therapeutics Market Analysis Summary

UAE Cytomegalovirus Therapeutics Market is valued at around $0.002 Mn in 2022 and is projected to reach $0.01 Mn by 2030, exhibiting a CAGR of 7.1% during the forecast period 2023-2030.

The widespread virus cytomegalovirus (CMV) can cause severe end-organ dysfunction in immunocompromised patients with congenital CMV illness, or it might be asymptomatic in healthy individuals. The herpesvirus family, Herpesviridae, or human herpesvirus-5, includes the human cytomegalovirus (HHV-5). Salivary glands and human cytomegalovirus infections are frequently linked. CMV infections may not cause any symptoms in healthy individuals, but they can be fatal in immunocompromised patients. Immunocompromised patients can develop a wide range of clinical illnesses from CMV, such as febrile syndromes, hepatitis, pneumonitis, retinitis, encephalopathy, esophagitis, and colitis.

The rise in the frequency of cytomegalovirus infection, investments in research & development, and the introduction of novel medicines are the main drivers of market growth for cytomegalovirus infection. In addition to Moderna, China Immunotech, Nobelpharma, Hookipa Biotech GmbH, Biotest, AlloVir, Merck Sharp & Dohme LLC, Chimerix, VBI Vaccines, Atara Biotherapeutics, SpyBiotech, MEMO Therapeutics, Lion TCR, and others, there are other significant in Cytomegalovirus Therapeutics market.

Market dynamics

Market Development

According to Takeda, Livtencity, or maribavir, has been approved by the FDA for use in patients 12 years of age and older who have post-transplant cytomegalovirus (CMV) infection and are resistant to one of four available medications. Takeda estimates that out of the 200,000 adult transplants performed each year around the world, roughly 25% of transplant recipients may get CMV infections. A peak sales estimate of $700 million to $800 million for Livtencity has been made by the Japanese pharmaceutical company using those numbers.

A leading Phase III programme for Cytomegalovirus (HHV-5) Infections has been developed for MRNA-1647, an M-RNA vaccine sold by Moderna. Preventing Cytomegalovirus (CMV) Disease in High-Risk Adult Kidney Transplant Recipients is a New Indication for PREVYMIS® (letermovir), a drug manufactured by Merck.

 

Market Drivers

Rise in the prevalence of cytomegalovirus infection

The market's growth rate between 2022 and 2030 is mostly driven by the rising prevalence of CMV infection. According to the Centers for Disease Control and Prevention, one in every 150 infants in the US is born with congenital cytomegalovirus (CMV) infection. Only one in five newborns who develop CMV go on to have long-term health problems. Due to increased infection rates and demand for better treatment options, the market for CMV infection treatment and diagnosis will grow.

Growing prevalence of viral infections

As AIDS patients' immune systems deteriorate, the prevalence of viral infections among them rises, increasing the requirement for anti-cytomegalovirus medications. In 2017, the CDC reported that 36.7 million persons worldwide were infected with the human immunodeficiency virus (HIV). It is anticipated that the availability of antiviral drugs to treat this ailment would increase demand for efficient treatment alternatives. This will affect how quickly the market expands.

Increase in the number of research and development activities      

In the upcoming years, it is predicted that the growing number of research and development initiatives for novel indications and the patent expiration of biologics would present new chances for the expansion of the cytomegalovirus market. Major institutes have started a number of projects centred on R&D initiatives related to CMV infection. For instance, in August 2019, the University of Washington's Program for Advanced Cell Therapy (PACT) began a pioneering cell-therapy trial for kidney transplant patients, using virus-specific white blood cells to treat patients with severe cytomegalovirus (CMV) infection following kidney transplantation.

Other drivers

Furthermore, the market for CMV will grow because of people's sedentary lifestyles and the increasing number of government campaigns to raise awareness. Along with this, growing healthcare costs and patent expirations that result in the availability of generic pharmaceuticals will accelerate the market's growth pace. Additionally, it is predicted that an increase in organ transplantation around the globe will accelerate market growth.

 

Market Restraints

The market for CMV treatments is being hampered by falling transplant rates and declining CMV prevalence brought on by highly active antiretroviral therapy (HAART). Cryotherapy and laser therapy are a couple of the alternatives that compete for market share.

The high price of the treatment, on the other hand, will limit the market's ability to expand. The cytomegalovirus market will face obstacles from a lack of healthcare facilities in emerging nations and a shortage of qualified workers. During the projection period of 2022–2030, lack of public awareness and drug side effects would also act as a restraint and limit market expansion.

This cytomegalovirus industry research contains information on the latest trends, trade laws, import-export analysis, production analysis, value chain optimization, market share, and the effects of domestic and international factors.

Key players

Gilead Sciences AbbVie Merck & Co. Bristol-Myers Squibb Roche Novartis Pfizer Sanofi AstraZeneca Takeda

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UAE Cytomegalovirus Therapeutics Market Segmentation

By Diagnosis

  • Serologic Test
  • Polymerase Chain Reaction (PCR) Test
  • Others

By Diseases

  • Retinitis
  • Pneumonia
  • Gastrointestinal Ulcers
  • Encephalitis
  • Others

By Drug

  • Cidofovir
  • Foscarnet
  • Valganciclovir
  • Ganciclovir
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Application

  • Stem Cell Transplantation
  • Organ Transplantation
  • Congenital CMV Infection
  • Other

By End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 04 July 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up